The HuR protein levels need to be tightly controlled, as its over-expression contributes to pathology, e.g. during inflammation or in the formation of cancer and its progression (Wang et al., 2013; Kotta-Loizou et al., 2014; Shang and Zhao, 2017). The gene discussed is ELAVL1; the disease is cancer.